Related Articles
Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways
Ganglioside GM3 exerts opposite effects on motility via epidermal growth factor receptor and hepatocyte growth factor receptor-mediated migration signaling
Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells
Anti‑breast cancer activity of selected 1,3,5‑triazines via modulation of EGFR‑TK
LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt-NF-κB activation